nodes	percent_of_prediction	percent_of_DWPC	metapath
Ezetimibe—ABCC3—Fluorouracil—pancreatic cancer	0.0623	0.0913	CbGbCtD
Ezetimibe—UGT2B7—Epirubicin—pancreatic cancer	0.0577	0.0845	CbGbCtD
Ezetimibe—UGT1A1—Erlotinib—pancreatic cancer	0.0537	0.0787	CbGbCtD
Ezetimibe—UGT1A1—Irinotecan—pancreatic cancer	0.0485	0.071	CbGbCtD
Ezetimibe—ABCC2—Tamoxifen—pancreatic cancer	0.0384	0.0563	CbGbCtD
Ezetimibe—ABCC3—Doxorubicin—pancreatic cancer	0.0355	0.0519	CbGbCtD
Ezetimibe—ABCG2—Tamoxifen—pancreatic cancer	0.0347	0.0509	CbGbCtD
Ezetimibe—SLCO1B1—Irinotecan—pancreatic cancer	0.0336	0.0492	CbGbCtD
Ezetimibe—ABCG2—Erlotinib—pancreatic cancer	0.0295	0.0433	CbGbCtD
Ezetimibe—ABCC2—Irinotecan—pancreatic cancer	0.0295	0.0432	CbGbCtD
Ezetimibe—ABCG2—Irinotecan—pancreatic cancer	0.0267	0.0391	CbGbCtD
Ezetimibe—ABCG2—Fluorouracil—pancreatic cancer	0.0256	0.0375	CbGbCtD
Ezetimibe—ABCC2—Docetaxel—pancreatic cancer	0.0216	0.0317	CbGbCtD
Ezetimibe—ABCC2—Sunitinib—pancreatic cancer	0.0215	0.0315	CbGbCtD
Ezetimibe—ABCG2—Docetaxel—pancreatic cancer	0.0196	0.0286	CbGbCtD
Ezetimibe—ABCG2—Sunitinib—pancreatic cancer	0.0195	0.0285	CbGbCtD
Ezetimibe—ABCC2—Doxorubicin—pancreatic cancer	0.0161	0.0236	CbGbCtD
Ezetimibe—ABCG2—Doxorubicin—pancreatic cancer	0.0146	0.0213	CbGbCtD
Ezetimibe—ANPEP—bile—pancreatic cancer	0.0137	0.122	CbGeAlD
Ezetimibe—ABCB1—Tamoxifen—pancreatic cancer	0.0125	0.0183	CbGbCtD
Ezetimibe—ABCG5—gall bladder—pancreatic cancer	0.0124	0.11	CbGeAlD
Ezetimibe—ABCG8—gall bladder—pancreatic cancer	0.011	0.0978	CbGeAlD
Ezetimibe—ABCB1—Gemcitabine—pancreatic cancer	0.0108	0.0158	CbGbCtD
Ezetimibe—ABCB1—Erlotinib—pancreatic cancer	0.0107	0.0156	CbGbCtD
Ezetimibe—ABCB1—Irinotecan—pancreatic cancer	0.00962	0.0141	CbGbCtD
Ezetimibe—ABCC3—bile duct—pancreatic cancer	0.0089	0.079	CbGeAlD
Ezetimibe—CYP3A4—Tamoxifen—pancreatic cancer	0.00751	0.011	CbGbCtD
Ezetimibe—ABCC2—bile duct—pancreatic cancer	0.00711	0.0631	CbGeAlD
Ezetimibe—ABCB1—Docetaxel—pancreatic cancer	0.00705	0.0103	CbGbCtD
Ezetimibe—ABCB1—Sunitinib—pancreatic cancer	0.00702	0.0103	CbGbCtD
Ezetimibe—CYP3A4—Erlotinib—pancreatic cancer	0.00638	0.00935	CbGbCtD
Ezetimibe—CYP3A4—Irinotecan—pancreatic cancer	0.00576	0.00844	CbGbCtD
Ezetimibe—ABCC2—bile—pancreatic cancer	0.00546	0.0485	CbGeAlD
Ezetimibe—ABCB1—Doxorubicin—pancreatic cancer	0.00526	0.0077	CbGbCtD
Ezetimibe—ABCG5—digestive system—pancreatic cancer	0.00487	0.0432	CbGeAlD
Ezetimibe—UGT2B15—gall bladder—pancreatic cancer	0.00463	0.0411	CbGeAlD
Ezetimibe—NPC1L1—digestive system—pancreatic cancer	0.00457	0.0406	CbGeAlD
Ezetimibe—ABCG8—digestive system—pancreatic cancer	0.00434	0.0385	CbGeAlD
Ezetimibe—CYP3A4—Docetaxel—pancreatic cancer	0.00422	0.00619	CbGbCtD
Ezetimibe—CYP3A4—Sunitinib—pancreatic cancer	0.0042	0.00616	CbGbCtD
Ezetimibe—SOAT1—gall bladder—pancreatic cancer	0.00398	0.0353	CbGeAlD
Ezetimibe—ANPEP—gall bladder—pancreatic cancer	0.00381	0.0338	CbGeAlD
Ezetimibe—CYP3A4—Doxorubicin—pancreatic cancer	0.00315	0.00461	CbGbCtD
Ezetimibe—UGT2B15—islet of Langerhans—pancreatic cancer	0.00303	0.0269	CbGeAlD
Ezetimibe—SOAT1—islet of Langerhans—pancreatic cancer	0.00261	0.0232	CbGeAlD
Ezetimibe—ANPEP—islet of Langerhans—pancreatic cancer	0.0025	0.0222	CbGeAlD
Ezetimibe—UGT2B15—pancreas—pancreatic cancer	0.00213	0.0189	CbGeAlD
Ezetimibe—UGT1A3—digestive system—pancreatic cancer	0.00194	0.0172	CbGeAlD
Ezetimibe—ABCC3—gall bladder—pancreatic cancer	0.0019	0.0168	CbGeAlD
Ezetimibe—SOAT1—pancreas—pancreatic cancer	0.00183	0.0163	CbGeAlD
Ezetimibe—UGT2B15—digestive system—pancreatic cancer	0.00182	0.0162	CbGeAlD
Ezetimibe—ANPEP—pancreas—pancreatic cancer	0.00175	0.0156	CbGeAlD
Ezetimibe—SOAT1—digestive system—pancreatic cancer	0.00157	0.0139	CbGeAlD
Ezetimibe—ANPEP—digestive system—pancreatic cancer	0.0015	0.0133	CbGeAlD
Ezetimibe—UGT2B7—digestive system—pancreatic cancer	0.00111	0.00987	CbGeAlD
Ezetimibe—UGT1A1—digestive system—pancreatic cancer	0.000946	0.0084	CbGeAlD
Ezetimibe—SLCO1B1—digestive system—pancreatic cancer	0.000787	0.00699	CbGeAlD
Ezetimibe—ABCC3—digestive system—pancreatic cancer	0.000747	0.00663	CbGeAlD
Ezetimibe—ABCC2—digestive system—pancreatic cancer	0.000597	0.0053	CbGeAlD
Ezetimibe—ABCB1—islet of Langerhans—pancreatic cancer	0.000357	0.00317	CbGeAlD
Ezetimibe—CYP3A4—digestive system—pancreatic cancer	0.000303	0.00269	CbGeAlD
Ezetimibe—ABCB1—pancreas—pancreatic cancer	0.000251	0.00223	CbGeAlD
Ezetimibe—ABCB1—digestive system—pancreatic cancer	0.000215	0.0019	CbGeAlD
Ezetimibe—Aspartate aminotransferase increased—Epirubicin—pancreatic cancer	0.000178	0.00116	CcSEcCtD
Ezetimibe—Dyspnoea—Fluorouracil—pancreatic cancer	0.000178	0.00116	CcSEcCtD
Ezetimibe—Mental disorder—Docetaxel—pancreatic cancer	0.000177	0.00116	CcSEcCtD
Ezetimibe—Nasopharyngitis—Epirubicin—pancreatic cancer	0.000176	0.00115	CcSEcCtD
Ezetimibe—Erythema—Docetaxel—pancreatic cancer	0.000176	0.00115	CcSEcCtD
Ezetimibe—Malnutrition—Docetaxel—pancreatic cancer	0.000176	0.00115	CcSEcCtD
Ezetimibe—Decreased appetite—Gemcitabine—pancreatic cancer	0.000176	0.00115	CcSEcCtD
Ezetimibe—Dyspepsia—Fluorouracil—pancreatic cancer	0.000175	0.00114	CcSEcCtD
Ezetimibe—Nausea—Tamoxifen—pancreatic cancer	0.000175	0.00114	CcSEcCtD
Ezetimibe—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.000175	0.00114	CcSEcCtD
Ezetimibe—Fatigue—Gemcitabine—pancreatic cancer	0.000175	0.00114	CcSEcCtD
Ezetimibe—Gastritis—Epirubicin—pancreatic cancer	0.000175	0.00114	CcSEcCtD
Ezetimibe—Muscular weakness—Epirubicin—pancreatic cancer	0.000174	0.00113	CcSEcCtD
Ezetimibe—Alanine aminotransferase increased—Epirubicin—pancreatic cancer	0.000174	0.00113	CcSEcCtD
Ezetimibe—Pain—Gemcitabine—pancreatic cancer	0.000173	0.00113	CcSEcCtD
Ezetimibe—Constipation—Gemcitabine—pancreatic cancer	0.000173	0.00113	CcSEcCtD
Ezetimibe—Nausea—Erlotinib—pancreatic cancer	0.000173	0.00113	CcSEcCtD
Ezetimibe—Decreased appetite—Fluorouracil—pancreatic cancer	0.000173	0.00113	CcSEcCtD
Ezetimibe—Diarrhoea—Sunitinib—pancreatic cancer	0.000173	0.00113	CcSEcCtD
Ezetimibe—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.000172	0.00112	CcSEcCtD
Ezetimibe—Feeling abnormal—Irinotecan—pancreatic cancer	0.000171	0.00112	CcSEcCtD
Ezetimibe—Influenza—Epirubicin—pancreatic cancer	0.000171	0.00111	CcSEcCtD
Ezetimibe—Back pain—Docetaxel—pancreatic cancer	0.00017	0.00111	CcSEcCtD
Ezetimibe—Pain—Fluorouracil—pancreatic cancer	0.00017	0.00111	CcSEcCtD
Ezetimibe—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.00017	0.00111	CcSEcCtD
Ezetimibe—Muscle spasms—Docetaxel—pancreatic cancer	0.000169	0.0011	CcSEcCtD
Ezetimibe—Eosinophilia—Epirubicin—pancreatic cancer	0.000169	0.0011	CcSEcCtD
Ezetimibe—Liver function test abnormal—Doxorubicin—pancreatic cancer	0.000169	0.0011	CcSEcCtD
Ezetimibe—Pancreatitis—Epirubicin—pancreatic cancer	0.000167	0.00109	CcSEcCtD
Ezetimibe—Dizziness—Sunitinib—pancreatic cancer	0.000167	0.00109	CcSEcCtD
Ezetimibe—Feeling abnormal—Gemcitabine—pancreatic cancer	0.000167	0.00109	CcSEcCtD
Ezetimibe—Breast disorder—Doxorubicin—pancreatic cancer	0.000165	0.00108	CcSEcCtD
Ezetimibe—Abdominal pain—Irinotecan—pancreatic cancer	0.000164	0.00107	CcSEcCtD
Ezetimibe—Body temperature increased—Irinotecan—pancreatic cancer	0.000164	0.00107	CcSEcCtD
Ezetimibe—Aspartate aminotransferase increased—Doxorubicin—pancreatic cancer	0.000164	0.00107	CcSEcCtD
Ezetimibe—Feeling abnormal—Fluorouracil—pancreatic cancer	0.000164	0.00107	CcSEcCtD
Ezetimibe—Nasopharyngitis—Doxorubicin—pancreatic cancer	0.000163	0.00106	CcSEcCtD
Ezetimibe—Anaemia—Docetaxel—pancreatic cancer	0.000163	0.00106	CcSEcCtD
Ezetimibe—Gastritis—Doxorubicin—pancreatic cancer	0.000162	0.00105	CcSEcCtD
Ezetimibe—Muscular weakness—Doxorubicin—pancreatic cancer	0.000161	0.00105	CcSEcCtD
Ezetimibe—Alanine aminotransferase increased—Doxorubicin—pancreatic cancer	0.000161	0.00105	CcSEcCtD
Ezetimibe—Vomiting—Sunitinib—pancreatic cancer	0.000161	0.00105	CcSEcCtD
Ezetimibe—Body temperature increased—Gemcitabine—pancreatic cancer	0.00016	0.00104	CcSEcCtD
Ezetimibe—Rash—Sunitinib—pancreatic cancer	0.000159	0.00104	CcSEcCtD
Ezetimibe—Dermatitis—Sunitinib—pancreatic cancer	0.000159	0.00104	CcSEcCtD
Ezetimibe—Upper respiratory tract infection—Epirubicin—pancreatic cancer	0.000159	0.00103	CcSEcCtD
Ezetimibe—Urticaria—Fluorouracil—pancreatic cancer	0.000158	0.00103	CcSEcCtD
Ezetimibe—Headache—Sunitinib—pancreatic cancer	0.000158	0.00103	CcSEcCtD
Ezetimibe—Influenza—Doxorubicin—pancreatic cancer	0.000158	0.00103	CcSEcCtD
Ezetimibe—Body temperature increased—Fluorouracil—pancreatic cancer	0.000157	0.00103	CcSEcCtD
Ezetimibe—Eosinophilia—Doxorubicin—pancreatic cancer	0.000156	0.00102	CcSEcCtD
Ezetimibe—Palpitations—Docetaxel—pancreatic cancer	0.000156	0.00101	CcSEcCtD
Ezetimibe—Photosensitivity reaction—Epirubicin—pancreatic cancer	0.000156	0.00101	CcSEcCtD
Ezetimibe—Pancreatitis—Doxorubicin—pancreatic cancer	0.000155	0.00101	CcSEcCtD
Ezetimibe—Cough—Docetaxel—pancreatic cancer	0.000154	0.001	CcSEcCtD
Ezetimibe—Hypersensitivity—Irinotecan—pancreatic cancer	0.000153	0.000999	CcSEcCtD
Ezetimibe—Hypertension—Docetaxel—pancreatic cancer	0.000152	0.000992	CcSEcCtD
Ezetimibe—Infestation NOS—Epirubicin—pancreatic cancer	0.000152	0.000991	CcSEcCtD
Ezetimibe—Infestation—Epirubicin—pancreatic cancer	0.000152	0.000991	CcSEcCtD
Ezetimibe—Myalgia—Docetaxel—pancreatic cancer	0.00015	0.000978	CcSEcCtD
Ezetimibe—Arthralgia—Docetaxel—pancreatic cancer	0.00015	0.000978	CcSEcCtD
Ezetimibe—Chest pain—Docetaxel—pancreatic cancer	0.00015	0.000978	CcSEcCtD
Ezetimibe—Nausea—Sunitinib—pancreatic cancer	0.00015	0.000978	CcSEcCtD
Ezetimibe—Asthenia—Irinotecan—pancreatic cancer	0.000149	0.000973	CcSEcCtD
Ezetimibe—Neuropathy peripheral—Epirubicin—pancreatic cancer	0.000149	0.000972	CcSEcCtD
Ezetimibe—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.000149	0.000971	CcSEcCtD
Ezetimibe—Jaundice—Epirubicin—pancreatic cancer	0.000148	0.000966	CcSEcCtD
Ezetimibe—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000147	0.000957	CcSEcCtD
Ezetimibe—Dry mouth—Docetaxel—pancreatic cancer	0.000147	0.000956	CcSEcCtD
Ezetimibe—Upper respiratory tract infection—Doxorubicin—pancreatic cancer	0.000147	0.000956	CcSEcCtD
Ezetimibe—Asthenia—Gemcitabine—pancreatic cancer	0.000145	0.000948	CcSEcCtD
Ezetimibe—Confusional state—Docetaxel—pancreatic cancer	0.000145	0.000945	CcSEcCtD
Ezetimibe—Photosensitivity reaction—Doxorubicin—pancreatic cancer	0.000144	0.000939	CcSEcCtD
Ezetimibe—Hepatobiliary disease—Epirubicin—pancreatic cancer	0.000144	0.000938	CcSEcCtD
Ezetimibe—Anaphylactic shock—Docetaxel—pancreatic cancer	0.000144	0.000937	CcSEcCtD
Ezetimibe—Pruritus—Gemcitabine—pancreatic cancer	0.000143	0.000935	CcSEcCtD
Ezetimibe—Infection—Docetaxel—pancreatic cancer	0.000143	0.000931	CcSEcCtD
Ezetimibe—Sinusitis—Epirubicin—pancreatic cancer	0.000143	0.00093	CcSEcCtD
Ezetimibe—Diarrhoea—Irinotecan—pancreatic cancer	0.000142	0.000928	CcSEcCtD
Ezetimibe—Nervous system disorder—Docetaxel—pancreatic cancer	0.000141	0.000919	CcSEcCtD
Ezetimibe—Pruritus—Fluorouracil—pancreatic cancer	0.000141	0.000919	CcSEcCtD
Ezetimibe—Thrombocytopenia—Docetaxel—pancreatic cancer	0.000141	0.000918	CcSEcCtD
Ezetimibe—Infestation—Doxorubicin—pancreatic cancer	0.000141	0.000917	CcSEcCtD
Ezetimibe—Infestation NOS—Doxorubicin—pancreatic cancer	0.000141	0.000917	CcSEcCtD
Ezetimibe—Skin disorder—Docetaxel—pancreatic cancer	0.00014	0.00091	CcSEcCtD
Ezetimibe—Diarrhoea—Gemcitabine—pancreatic cancer	0.000139	0.000904	CcSEcCtD
Ezetimibe—Neuropathy peripheral—Doxorubicin—pancreatic cancer	0.000138	0.000899	CcSEcCtD
Ezetimibe—Dizziness—Irinotecan—pancreatic cancer	0.000138	0.000897	CcSEcCtD
Ezetimibe—Jaundice—Doxorubicin—pancreatic cancer	0.000137	0.000894	CcSEcCtD
Ezetimibe—Hepatitis—Epirubicin—pancreatic cancer	0.000137	0.00089	CcSEcCtD
Ezetimibe—Diarrhoea—Fluorouracil—pancreatic cancer	0.000136	0.000889	CcSEcCtD
Ezetimibe—Pharyngitis—Epirubicin—pancreatic cancer	0.000135	0.000883	CcSEcCtD
Ezetimibe—Oedema peripheral—Epirubicin—pancreatic cancer	0.000134	0.000877	CcSEcCtD
Ezetimibe—Connective tissue disorder—Epirubicin—pancreatic cancer	0.000134	0.000874	CcSEcCtD
Ezetimibe—Hepatobiliary disease—Doxorubicin—pancreatic cancer	0.000133	0.000867	CcSEcCtD
Ezetimibe—Vomiting—Irinotecan—pancreatic cancer	0.000132	0.000862	CcSEcCtD
Ezetimibe—Sinusitis—Doxorubicin—pancreatic cancer	0.000132	0.000861	CcSEcCtD
Ezetimibe—Dizziness—Fluorouracil—pancreatic cancer	0.000132	0.000859	CcSEcCtD
Ezetimibe—Rash—Irinotecan—pancreatic cancer	0.000131	0.000855	CcSEcCtD
Ezetimibe—Dermatitis—Irinotecan—pancreatic cancer	0.000131	0.000854	CcSEcCtD
Ezetimibe—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.000131	0.000854	CcSEcCtD
Ezetimibe—Headache—Irinotecan—pancreatic cancer	0.00013	0.000849	CcSEcCtD
Ezetimibe—Insomnia—Docetaxel—pancreatic cancer	0.00013	0.000848	CcSEcCtD
Ezetimibe—Paraesthesia—Docetaxel—pancreatic cancer	0.000129	0.000842	CcSEcCtD
Ezetimibe—Erythema multiforme—Epirubicin—pancreatic cancer	0.000129	0.000841	CcSEcCtD
Ezetimibe—Vomiting—Gemcitabine—pancreatic cancer	0.000129	0.00084	CcSEcCtD
Ezetimibe—Dyspnoea—Docetaxel—pancreatic cancer	0.000128	0.000836	CcSEcCtD
Ezetimibe—Rash—Gemcitabine—pancreatic cancer	0.000128	0.000833	CcSEcCtD
Ezetimibe—Dermatitis—Gemcitabine—pancreatic cancer	0.000128	0.000832	CcSEcCtD
Ezetimibe—Headache—Gemcitabine—pancreatic cancer	0.000127	0.000827	CcSEcCtD
Ezetimibe—Flushing—Epirubicin—pancreatic cancer	0.000127	0.000826	CcSEcCtD
Ezetimibe—Vomiting—Fluorouracil—pancreatic cancer	0.000127	0.000826	CcSEcCtD
Ezetimibe—Dyspepsia—Docetaxel—pancreatic cancer	0.000127	0.000825	CcSEcCtD
Ezetimibe—Hepatitis—Doxorubicin—pancreatic cancer	0.000126	0.000823	CcSEcCtD
Ezetimibe—Rash—Fluorouracil—pancreatic cancer	0.000126	0.000819	CcSEcCtD
Ezetimibe—Dermatitis—Fluorouracil—pancreatic cancer	0.000125	0.000818	CcSEcCtD
Ezetimibe—Pharyngitis—Doxorubicin—pancreatic cancer	0.000125	0.000817	CcSEcCtD
Ezetimibe—Decreased appetite—Docetaxel—pancreatic cancer	0.000125	0.000815	CcSEcCtD
Ezetimibe—Headache—Fluorouracil—pancreatic cancer	0.000125	0.000814	CcSEcCtD
Ezetimibe—Oedema peripheral—Doxorubicin—pancreatic cancer	0.000124	0.000811	CcSEcCtD
Ezetimibe—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000124	0.000809	CcSEcCtD
Ezetimibe—Connective tissue disorder—Doxorubicin—pancreatic cancer	0.000124	0.000809	CcSEcCtD
Ezetimibe—Fatigue—Docetaxel—pancreatic cancer	0.000124	0.000808	CcSEcCtD
Ezetimibe—Angiopathy—Epirubicin—pancreatic cancer	0.000124	0.000807	CcSEcCtD
Ezetimibe—Nausea—Irinotecan—pancreatic cancer	0.000124	0.000805	CcSEcCtD
Ezetimibe—Immune system disorder—Epirubicin—pancreatic cancer	0.000123	0.000804	CcSEcCtD
Ezetimibe—Mediastinal disorder—Epirubicin—pancreatic cancer	0.000123	0.000802	CcSEcCtD
Ezetimibe—Pain—Docetaxel—pancreatic cancer	0.000123	0.000802	CcSEcCtD
Ezetimibe—Constipation—Docetaxel—pancreatic cancer	0.000123	0.000802	CcSEcCtD
Ezetimibe—Alopecia—Epirubicin—pancreatic cancer	0.000121	0.000786	CcSEcCtD
Ezetimibe—Nausea—Gemcitabine—pancreatic cancer	0.00012	0.000785	CcSEcCtD
Ezetimibe—Mental disorder—Epirubicin—pancreatic cancer	0.00012	0.00078	CcSEcCtD
Ezetimibe—Erythema multiforme—Doxorubicin—pancreatic cancer	0.000119	0.000779	CcSEcCtD
Ezetimibe—Erythema—Epirubicin—pancreatic cancer	0.000119	0.000775	CcSEcCtD
Ezetimibe—Malnutrition—Epirubicin—pancreatic cancer	0.000119	0.000775	CcSEcCtD
Ezetimibe—Feeling abnormal—Docetaxel—pancreatic cancer	0.000118	0.000772	CcSEcCtD
Ezetimibe—Nausea—Fluorouracil—pancreatic cancer	0.000118	0.000771	CcSEcCtD
Ezetimibe—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000118	0.000766	CcSEcCtD
Ezetimibe—Flushing—Doxorubicin—pancreatic cancer	0.000117	0.000764	CcSEcCtD
Ezetimibe—Flatulence—Epirubicin—pancreatic cancer	0.000117	0.000763	CcSEcCtD
Ezetimibe—Back pain—Epirubicin—pancreatic cancer	0.000115	0.000749	CcSEcCtD
Ezetimibe—Angiopathy—Doxorubicin—pancreatic cancer	0.000115	0.000747	CcSEcCtD
Ezetimibe—Muscle spasms—Epirubicin—pancreatic cancer	0.000114	0.000745	CcSEcCtD
Ezetimibe—Immune system disorder—Doxorubicin—pancreatic cancer	0.000114	0.000744	CcSEcCtD
Ezetimibe—Mediastinal disorder—Doxorubicin—pancreatic cancer	0.000114	0.000742	CcSEcCtD
Ezetimibe—Abdominal pain—Docetaxel—pancreatic cancer	0.000114	0.000741	CcSEcCtD
Ezetimibe—Body temperature increased—Docetaxel—pancreatic cancer	0.000114	0.000741	CcSEcCtD
Ezetimibe—Alopecia—Doxorubicin—pancreatic cancer	0.000112	0.000728	CcSEcCtD
Ezetimibe—Mental disorder—Doxorubicin—pancreatic cancer	0.000111	0.000721	CcSEcCtD
Ezetimibe—Ill-defined disorder—Epirubicin—pancreatic cancer	0.00011	0.000719	CcSEcCtD
Ezetimibe—Malnutrition—Doxorubicin—pancreatic cancer	0.00011	0.000717	CcSEcCtD
Ezetimibe—Erythema—Doxorubicin—pancreatic cancer	0.00011	0.000717	CcSEcCtD
Ezetimibe—Anaemia—Epirubicin—pancreatic cancer	0.00011	0.000716	CcSEcCtD
Ezetimibe—Flatulence—Doxorubicin—pancreatic cancer	0.000108	0.000706	CcSEcCtD
Ezetimibe—Malaise—Epirubicin—pancreatic cancer	0.000107	0.000699	CcSEcCtD
Ezetimibe—Back pain—Doxorubicin—pancreatic cancer	0.000106	0.000693	CcSEcCtD
Ezetimibe—Hypersensitivity—Docetaxel—pancreatic cancer	0.000106	0.000691	CcSEcCtD
Ezetimibe—Muscle spasms—Doxorubicin—pancreatic cancer	0.000106	0.000689	CcSEcCtD
Ezetimibe—Palpitations—Epirubicin—pancreatic cancer	0.000105	0.000685	CcSEcCtD
Ezetimibe—Cough—Epirubicin—pancreatic cancer	0.000104	0.000676	CcSEcCtD
Ezetimibe—Asthenia—Docetaxel—pancreatic cancer	0.000103	0.000673	CcSEcCtD
Ezetimibe—Hypertension—Epirubicin—pancreatic cancer	0.000103	0.000669	CcSEcCtD
Ezetimibe—Ill-defined disorder—Doxorubicin—pancreatic cancer	0.000102	0.000665	CcSEcCtD
Ezetimibe—Pruritus—Docetaxel—pancreatic cancer	0.000102	0.000663	CcSEcCtD
Ezetimibe—Anaemia—Doxorubicin—pancreatic cancer	0.000102	0.000663	CcSEcCtD
Ezetimibe—Arthralgia—Epirubicin—pancreatic cancer	0.000101	0.00066	CcSEcCtD
Ezetimibe—Chest pain—Epirubicin—pancreatic cancer	0.000101	0.00066	CcSEcCtD
Ezetimibe—Myalgia—Epirubicin—pancreatic cancer	0.000101	0.00066	CcSEcCtD
Ezetimibe—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.0001	0.000655	CcSEcCtD
Ezetimibe—Discomfort—Epirubicin—pancreatic cancer	0.0001	0.000652	CcSEcCtD
Ezetimibe—Malaise—Doxorubicin—pancreatic cancer	9.92e-05	0.000646	CcSEcCtD
Ezetimibe—Dry mouth—Epirubicin—pancreatic cancer	9.89e-05	0.000645	CcSEcCtD
Ezetimibe—Diarrhoea—Docetaxel—pancreatic cancer	9.84e-05	0.000641	CcSEcCtD
Ezetimibe—Confusional state—Epirubicin—pancreatic cancer	9.78e-05	0.000637	CcSEcCtD
Ezetimibe—Palpitations—Doxorubicin—pancreatic cancer	9.72e-05	0.000633	CcSEcCtD
Ezetimibe—Anaphylactic shock—Epirubicin—pancreatic cancer	9.7e-05	0.000632	CcSEcCtD
Ezetimibe—Infection—Epirubicin—pancreatic cancer	9.63e-05	0.000628	CcSEcCtD
Ezetimibe—Cough—Doxorubicin—pancreatic cancer	9.59e-05	0.000625	CcSEcCtD
Ezetimibe—Nervous system disorder—Epirubicin—pancreatic cancer	9.51e-05	0.00062	CcSEcCtD
Ezetimibe—Dizziness—Docetaxel—pancreatic cancer	9.51e-05	0.00062	CcSEcCtD
Ezetimibe—Thrombocytopenia—Epirubicin—pancreatic cancer	9.5e-05	0.000619	CcSEcCtD
Ezetimibe—Hypertension—Doxorubicin—pancreatic cancer	9.49e-05	0.000619	CcSEcCtD
Ezetimibe—Skin disorder—Epirubicin—pancreatic cancer	9.42e-05	0.000614	CcSEcCtD
Ezetimibe—Arthralgia—Doxorubicin—pancreatic cancer	9.36e-05	0.00061	CcSEcCtD
Ezetimibe—Myalgia—Doxorubicin—pancreatic cancer	9.36e-05	0.00061	CcSEcCtD
Ezetimibe—Chest pain—Doxorubicin—pancreatic cancer	9.36e-05	0.00061	CcSEcCtD
Ezetimibe—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	9.3e-05	0.000606	CcSEcCtD
Ezetimibe—Discomfort—Doxorubicin—pancreatic cancer	9.25e-05	0.000603	CcSEcCtD
Ezetimibe—Dry mouth—Doxorubicin—pancreatic cancer	9.15e-05	0.000597	CcSEcCtD
Ezetimibe—Vomiting—Docetaxel—pancreatic cancer	9.14e-05	0.000596	CcSEcCtD
Ezetimibe—Rash—Docetaxel—pancreatic cancer	9.07e-05	0.000591	CcSEcCtD
Ezetimibe—Dermatitis—Docetaxel—pancreatic cancer	9.06e-05	0.00059	CcSEcCtD
Ezetimibe—Confusional state—Doxorubicin—pancreatic cancer	9.05e-05	0.00059	CcSEcCtD
Ezetimibe—Headache—Docetaxel—pancreatic cancer	9.01e-05	0.000587	CcSEcCtD
Ezetimibe—Anaphylactic shock—Doxorubicin—pancreatic cancer	8.97e-05	0.000585	CcSEcCtD
Ezetimibe—Infection—Doxorubicin—pancreatic cancer	8.91e-05	0.000581	CcSEcCtD
Ezetimibe—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	8.84e-05	0.000576	CcSEcCtD
Ezetimibe—Nervous system disorder—Doxorubicin—pancreatic cancer	8.8e-05	0.000574	CcSEcCtD
Ezetimibe—Thrombocytopenia—Doxorubicin—pancreatic cancer	8.79e-05	0.000573	CcSEcCtD
Ezetimibe—Insomnia—Epirubicin—pancreatic cancer	8.77e-05	0.000572	CcSEcCtD
Ezetimibe—Skin disorder—Doxorubicin—pancreatic cancer	8.72e-05	0.000568	CcSEcCtD
Ezetimibe—Paraesthesia—Epirubicin—pancreatic cancer	8.71e-05	0.000568	CcSEcCtD
Ezetimibe—Dyspnoea—Epirubicin—pancreatic cancer	8.65e-05	0.000564	CcSEcCtD
Ezetimibe—Nausea—Docetaxel—pancreatic cancer	8.54e-05	0.000557	CcSEcCtD
Ezetimibe—Dyspepsia—Epirubicin—pancreatic cancer	8.54e-05	0.000557	CcSEcCtD
Ezetimibe—Decreased appetite—Epirubicin—pancreatic cancer	8.43e-05	0.00055	CcSEcCtD
Ezetimibe—Gastrointestinal disorder—Epirubicin—pancreatic cancer	8.37e-05	0.000546	CcSEcCtD
Ezetimibe—Fatigue—Epirubicin—pancreatic cancer	8.36e-05	0.000545	CcSEcCtD
Ezetimibe—Pain—Epirubicin—pancreatic cancer	8.29e-05	0.000541	CcSEcCtD
Ezetimibe—Constipation—Epirubicin—pancreatic cancer	8.29e-05	0.000541	CcSEcCtD
Ezetimibe—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	8.18e-05	0.000533	CcSEcCtD
Ezetimibe—Insomnia—Doxorubicin—pancreatic cancer	8.12e-05	0.000529	CcSEcCtD
Ezetimibe—Paraesthesia—Doxorubicin—pancreatic cancer	8.06e-05	0.000525	CcSEcCtD
Ezetimibe—Dyspnoea—Doxorubicin—pancreatic cancer	8e-05	0.000522	CcSEcCtD
Ezetimibe—Feeling abnormal—Epirubicin—pancreatic cancer	7.99e-05	0.000521	CcSEcCtD
Ezetimibe—Gastrointestinal pain—Epirubicin—pancreatic cancer	7.93e-05	0.000517	CcSEcCtD
Ezetimibe—Dyspepsia—Doxorubicin—pancreatic cancer	7.9e-05	0.000515	CcSEcCtD
Ezetimibe—Decreased appetite—Doxorubicin—pancreatic cancer	7.8e-05	0.000509	CcSEcCtD
Ezetimibe—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	7.75e-05	0.000505	CcSEcCtD
Ezetimibe—Fatigue—Doxorubicin—pancreatic cancer	7.74e-05	0.000504	CcSEcCtD
Ezetimibe—Urticaria—Epirubicin—pancreatic cancer	7.7e-05	0.000502	CcSEcCtD
Ezetimibe—Constipation—Doxorubicin—pancreatic cancer	7.67e-05	0.0005	CcSEcCtD
Ezetimibe—Pain—Doxorubicin—pancreatic cancer	7.67e-05	0.0005	CcSEcCtD
Ezetimibe—Abdominal pain—Epirubicin—pancreatic cancer	7.67e-05	0.0005	CcSEcCtD
Ezetimibe—Body temperature increased—Epirubicin—pancreatic cancer	7.67e-05	0.0005	CcSEcCtD
Ezetimibe—Feeling abnormal—Doxorubicin—pancreatic cancer	7.39e-05	0.000482	CcSEcCtD
Ezetimibe—Gastrointestinal pain—Doxorubicin—pancreatic cancer	7.34e-05	0.000478	CcSEcCtD
Ezetimibe—Hypersensitivity—Epirubicin—pancreatic cancer	7.15e-05	0.000466	CcSEcCtD
Ezetimibe—Urticaria—Doxorubicin—pancreatic cancer	7.13e-05	0.000465	CcSEcCtD
Ezetimibe—Abdominal pain—Doxorubicin—pancreatic cancer	7.09e-05	0.000462	CcSEcCtD
Ezetimibe—Body temperature increased—Doxorubicin—pancreatic cancer	7.09e-05	0.000462	CcSEcCtD
Ezetimibe—Asthenia—Epirubicin—pancreatic cancer	6.96e-05	0.000454	CcSEcCtD
Ezetimibe—Pruritus—Epirubicin—pancreatic cancer	6.86e-05	0.000447	CcSEcCtD
Ezetimibe—Diarrhoea—Epirubicin—pancreatic cancer	6.64e-05	0.000433	CcSEcCtD
Ezetimibe—Hypersensitivity—Doxorubicin—pancreatic cancer	6.61e-05	0.000431	CcSEcCtD
Ezetimibe—Asthenia—Doxorubicin—pancreatic cancer	6.44e-05	0.00042	CcSEcCtD
Ezetimibe—Dizziness—Epirubicin—pancreatic cancer	6.41e-05	0.000418	CcSEcCtD
Ezetimibe—Pruritus—Doxorubicin—pancreatic cancer	6.35e-05	0.000414	CcSEcCtD
Ezetimibe—Vomiting—Epirubicin—pancreatic cancer	6.17e-05	0.000402	CcSEcCtD
Ezetimibe—Diarrhoea—Doxorubicin—pancreatic cancer	6.14e-05	0.0004	CcSEcCtD
Ezetimibe—Rash—Epirubicin—pancreatic cancer	6.11e-05	0.000399	CcSEcCtD
Ezetimibe—Dermatitis—Epirubicin—pancreatic cancer	6.11e-05	0.000398	CcSEcCtD
Ezetimibe—Headache—Epirubicin—pancreatic cancer	6.08e-05	0.000396	CcSEcCtD
Ezetimibe—Dizziness—Doxorubicin—pancreatic cancer	5.93e-05	0.000387	CcSEcCtD
Ezetimibe—Nausea—Epirubicin—pancreatic cancer	5.76e-05	0.000376	CcSEcCtD
Ezetimibe—Vomiting—Doxorubicin—pancreatic cancer	5.71e-05	0.000372	CcSEcCtD
Ezetimibe—Rash—Doxorubicin—pancreatic cancer	5.66e-05	0.000369	CcSEcCtD
Ezetimibe—Dermatitis—Doxorubicin—pancreatic cancer	5.65e-05	0.000369	CcSEcCtD
Ezetimibe—Headache—Doxorubicin—pancreatic cancer	5.62e-05	0.000366	CcSEcCtD
Ezetimibe—UGT1A3—Metabolism—PRSS1—pancreatic cancer	5.44e-05	0.00107	CbGpPWpGaD
Ezetimibe—Nausea—Doxorubicin—pancreatic cancer	5.33e-05	0.000347	CcSEcCtD
Ezetimibe—NPC1L1—Metabolism—PIK3CD—pancreatic cancer	5.26e-05	0.00103	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—SHH—pancreatic cancer	5.08e-05	0.000995	CbGpPWpGaD
Ezetimibe—ABCG8—Metabolism—APOE—pancreatic cancer	5.03e-05	0.000984	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—IAPP—pancreatic cancer	5.02e-05	0.000983	CbGpPWpGaD
Ezetimibe—UGT1A3—NRF2 pathway—TGFB1—pancreatic cancer	5.01e-05	0.00098	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism—APOE—pancreatic cancer	4.84e-05	0.000947	CbGpPWpGaD
Ezetimibe—ABCG8—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	4.76e-05	0.000931	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—ARG2—pancreatic cancer	4.72e-05	0.000924	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—PRSS1—pancreatic cancer	4.63e-05	0.000906	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—PRSS1—pancreatic cancer	4.63e-05	0.000906	CbGpPWpGaD
Ezetimibe—NPC1L1—Metabolism—PIK3CB—pancreatic cancer	4.59e-05	0.000898	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	4.58e-05	0.000896	CbGpPWpGaD
Ezetimibe—NPC1L1—Metabolism—PTGS2—pancreatic cancer	4.54e-05	0.00089	CbGpPWpGaD
Ezetimibe—ABCG8—Metabolism—PIK3CG—pancreatic cancer	4.54e-05	0.000888	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—CD44—pancreatic cancer	4.49e-05	0.000879	CbGpPWpGaD
Ezetimibe—ABCC2—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	4.47e-05	0.000875	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—EZH2—pancreatic cancer	4.39e-05	0.000859	CbGpPWpGaD
Ezetimibe—ABCG8—Metabolism—PPARG—pancreatic cancer	4.38e-05	0.000857	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism—PIK3CG—pancreatic cancer	4.37e-05	0.000855	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—GADD45A—pancreatic cancer	4.31e-05	0.000845	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—GCG—pancreatic cancer	4.3e-05	0.000842	CbGpPWpGaD
Ezetimibe—ABCC3—NRF2 pathway—TGFB1—pancreatic cancer	4.26e-05	0.000834	CbGpPWpGaD
Ezetimibe—UGT2B7—NRF2 pathway—TGFB1—pancreatic cancer	4.26e-05	0.000834	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism—PPARG—pancreatic cancer	4.21e-05	0.000825	CbGpPWpGaD
Ezetimibe—SLCO1B1—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	4.2e-05	0.000822	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—TYMP—pancreatic cancer	4.13e-05	0.000808	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—STK11—pancreatic cancer	4.05e-05	0.000792	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—ARG2—pancreatic cancer	4.01e-05	0.000786	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—ARG2—pancreatic cancer	4.01e-05	0.000786	CbGpPWpGaD
Ezetimibe—ABCG8—Metabolism—PIK3CD—pancreatic cancer	3.99e-05	0.000781	CbGpPWpGaD
Ezetimibe—NPC1L1—Metabolism—PTEN—pancreatic cancer	3.96e-05	0.000776	CbGpPWpGaD
Ezetimibe—ABCG2—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	3.89e-05	0.000761	CbGpPWpGaD
Ezetimibe—ABCG2—HIF-1-alpha transcription factor network—AKT1—pancreatic cancer	3.85e-05	0.000754	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism—PIK3CD—pancreatic cancer	3.84e-05	0.000751	CbGpPWpGaD
Ezetimibe—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—pancreatic cancer	3.81e-05	0.000746	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—PRSS1—pancreatic cancer	3.76e-05	0.000736	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—STK11—pancreatic cancer	3.69e-05	0.000723	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—TYMP—pancreatic cancer	3.51e-05	0.000687	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—TYMP—pancreatic cancer	3.51e-05	0.000687	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—TYMS—pancreatic cancer	3.48e-05	0.000681	CbGpPWpGaD
Ezetimibe—ABCB1—Allograft Rejection—CXCL8—pancreatic cancer	3.48e-05	0.000681	CbGpPWpGaD
Ezetimibe—ABCG8—Metabolism—PIK3CB—pancreatic cancer	3.48e-05	0.00068	CbGpPWpGaD
Ezetimibe—UGT1A1—NRF2 pathway—TGFB1—pancreatic cancer	3.46e-05	0.000677	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—PRSS1—pancreatic cancer	3.45e-05	0.000675	CbGpPWpGaD
Ezetimibe—ABCG8—Metabolism—PTGS2—pancreatic cancer	3.44e-05	0.000674	CbGpPWpGaD
Ezetimibe—ABCC2—NRF2 pathway—TGFB1—pancreatic cancer	3.38e-05	0.000661	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism—PIK3CB—pancreatic cancer	3.35e-05	0.000655	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—pancreatic cancer	3.34e-05	0.000654	CbGpPWpGaD
Ezetimibe—ABCB1—Allograft Rejection—CASP3—pancreatic cancer	3.33e-05	0.000652	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—GLP1R—pancreatic cancer	3.33e-05	0.000651	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism—PTGS2—pancreatic cancer	3.31e-05	0.000649	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—DPYD—pancreatic cancer	3.27e-05	0.000641	CbGpPWpGaD
Ezetimibe—ABCB1—HIF-1-alpha transcription factor network—VEGFA—pancreatic cancer	3.26e-05	0.000639	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—ARG2—pancreatic cancer	3.26e-05	0.000638	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—SMAD4—pancreatic cancer	3.24e-05	0.000633	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—PRSS1—pancreatic cancer	3.19e-05	0.000625	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—pancreatic cancer	3.18e-05	0.000622	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—SLC2A2—pancreatic cancer	3.1e-05	0.000608	CbGpPWpGaD
Ezetimibe—ABCG8—Metabolism—PTEN—pancreatic cancer	3e-05	0.000588	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—ARG2—pancreatic cancer	2.99e-05	0.000585	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	2.89e-05	0.000567	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism—PTEN—pancreatic cancer	2.89e-05	0.000566	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—TYMP—pancreatic cancer	2.85e-05	0.000558	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—APOE—pancreatic cancer	2.83e-05	0.000554	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—GLP1R—pancreatic cancer	2.83e-05	0.000554	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—GLP1R—pancreatic cancer	2.83e-05	0.000554	CbGpPWpGaD
Ezetimibe—ABCB1—Allograft Rejection—VEGFA—pancreatic cancer	2.83e-05	0.000553	CbGpPWpGaD
Ezetimibe—NPC1L1—Metabolism—PIK3CA—pancreatic cancer	2.8e-05	0.000547	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—DPYD—pancreatic cancer	2.78e-05	0.000545	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—DPYD—pancreatic cancer	2.78e-05	0.000545	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—ARG2—pancreatic cancer	2.77e-05	0.000542	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—SLC2A2—pancreatic cancer	2.64e-05	0.000517	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—SLC2A2—pancreatic cancer	2.64e-05	0.000517	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	2.61e-05	0.000511	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—TYMP—pancreatic cancer	2.61e-05	0.000511	CbGpPWpGaD
Ezetimibe—ABCB1—Allograft Rejection—TGFB1—pancreatic cancer	2.59e-05	0.000508	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—PIK3CG—pancreatic cancer	2.55e-05	0.0005	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	2.52e-05	0.000494	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—PPARG—pancreatic cancer	2.47e-05	0.000483	CbGpPWpGaD
Ezetimibe—ABCB1—Allograft Rejection—TNF—pancreatic cancer	2.42e-05	0.000474	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—TYMP—pancreatic cancer	2.42e-05	0.000474	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—pancreatic cancer	2.41e-05	0.000471	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—CD44—pancreatic cancer	2.4e-05	0.000471	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—EGF—pancreatic cancer	2.31e-05	0.000451	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—GCG—pancreatic cancer	2.31e-05	0.000451	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—GLP1R—pancreatic cancer	2.3e-05	0.00045	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	2.3e-05	0.00045	CbGpPWpGaD
Ezetimibe—NPC1L1—Metabolism—AKT1—pancreatic cancer	2.28e-05	0.000447	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—DPYD—pancreatic cancer	2.26e-05	0.000443	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—PIK3CD—pancreatic cancer	2.25e-05	0.00044	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—STK11—pancreatic cancer	2.17e-05	0.000424	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	2.16e-05	0.000422	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—SLC2A2—pancreatic cancer	2.15e-05	0.00042	CbGpPWpGaD
Ezetimibe—ABCG8—Metabolism—PIK3CA—pancreatic cancer	2.12e-05	0.000415	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—GLP1R—pancreatic cancer	2.11e-05	0.000412	CbGpPWpGaD
Ezetimibe—ABCB1—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	2.1e-05	0.000411	CbGpPWpGaD
Ezetimibe—ABCB1—HIF-1-alpha transcription factor network—AKT1—pancreatic cancer	2.08e-05	0.000408	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—DPYD—pancreatic cancer	2.07e-05	0.000406	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—CD44—pancreatic cancer	2.04e-05	0.0004	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—CD44—pancreatic cancer	2.04e-05	0.0004	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism—PIK3CA—pancreatic cancer	2.04e-05	0.000399	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	2e-05	0.000392	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	1.98e-05	0.000388	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—SLC2A2—pancreatic cancer	1.97e-05	0.000385	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—GCG—pancreatic cancer	1.96e-05	0.000384	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—GCG—pancreatic cancer	1.96e-05	0.000384	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—PIK3CB—pancreatic cancer	1.96e-05	0.000383	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—GLP1R—pancreatic cancer	1.95e-05	0.000382	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	1.95e-05	0.000381	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—PTGS2—pancreatic cancer	1.94e-05	0.00038	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—DPYD—pancreatic cancer	1.92e-05	0.000376	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	1.88e-05	0.000368	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—TYMS—pancreatic cancer	1.86e-05	0.000365	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—STK11—pancreatic cancer	1.84e-05	0.000361	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—STK11—pancreatic cancer	1.84e-05	0.000361	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—SLC2A2—pancreatic cancer	1.82e-05	0.000356	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—pancreatic cancer	1.77e-05	0.000347	CbGpPWpGaD
Ezetimibe—ABCG8—Metabolism—AKT1—pancreatic cancer	1.73e-05	0.000339	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	1.73e-05	0.000339	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—PRSS1—pancreatic cancer	1.73e-05	0.000338	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	1.71e-05	0.000335	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—PTEN—pancreatic cancer	1.69e-05	0.000331	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism—AKT1—pancreatic cancer	1.67e-05	0.000326	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—CD44—pancreatic cancer	1.66e-05	0.000325	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—pancreatic cancer	1.64e-05	0.000322	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—pancreatic cancer	1.6e-05	0.000313	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—GCG—pancreatic cancer	1.59e-05	0.000312	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—TYMS—pancreatic cancer	1.59e-05	0.00031	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—TYMS—pancreatic cancer	1.59e-05	0.00031	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—pancreatic cancer	1.58e-05	0.00031	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—pancreatic cancer	1.54e-05	0.000302	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—CD44—pancreatic cancer	1.52e-05	0.000298	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—APOE—pancreatic cancer	1.52e-05	0.000297	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—STK11—pancreatic cancer	1.5e-05	0.000293	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—ARG2—pancreatic cancer	1.5e-05	0.000293	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	1.49e-05	0.000292	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	1.48e-05	0.000289	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—GCG—pancreatic cancer	1.46e-05	0.000286	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—pancreatic cancer	1.43e-05	0.00028	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—CD44—pancreatic cancer	1.41e-05	0.000276	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—pancreatic cancer	1.39e-05	0.000273	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—STK11—pancreatic cancer	1.37e-05	0.000269	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—PIK3CG—pancreatic cancer	1.37e-05	0.000268	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—GCG—pancreatic cancer	1.35e-05	0.000265	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—PPARG—pancreatic cancer	1.32e-05	0.000259	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—TYMP—pancreatic cancer	1.31e-05	0.000256	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—APOE—pancreatic cancer	1.29e-05	0.000252	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—APOE—pancreatic cancer	1.29e-05	0.000252	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—TYMS—pancreatic cancer	1.29e-05	0.000252	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	1.29e-05	0.000252	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—pancreatic cancer	1.28e-05	0.000251	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—pancreatic cancer	1.28e-05	0.000251	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—STK11—pancreatic cancer	1.27e-05	0.000249	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—pancreatic cancer	1.26e-05	0.000246	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	1.22e-05	0.000239	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—PIK3CD—pancreatic cancer	1.2e-05	0.000236	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—pancreatic cancer	1.2e-05	0.000234	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—PIK3CA—pancreatic cancer	1.19e-05	0.000234	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—pancreatic cancer	1.19e-05	0.000232	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—TYMS—pancreatic cancer	1.18e-05	0.000231	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—PIK3CG—pancreatic cancer	1.16e-05	0.000228	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—PIK3CG—pancreatic cancer	1.16e-05	0.000228	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—PPARG—pancreatic cancer	1.12e-05	0.00022	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—PPARG—pancreatic cancer	1.12e-05	0.00022	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—TYMS—pancreatic cancer	1.09e-05	0.000214	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—pancreatic cancer	1.09e-05	0.000213	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—PRSS1—pancreatic cancer	1.06e-05	0.000208	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—GLP1R—pancreatic cancer	1.05e-05	0.000206	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—pancreatic cancer	1.05e-05	0.000206	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—PIK3CB—pancreatic cancer	1.05e-05	0.000205	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—APOE—pancreatic cancer	1.05e-05	0.000205	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—PTGS2—pancreatic cancer	1.04e-05	0.000203	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—DPYD—pancreatic cancer	1.04e-05	0.000203	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—PIK3CD—pancreatic cancer	1.02e-05	0.0002	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—PIK3CD—pancreatic cancer	1.02e-05	0.0002	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—SLC2A2—pancreatic cancer	9.84e-06	0.000193	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—AKT1—pancreatic cancer	9.75e-06	0.000191	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—APOE—pancreatic cancer	9.6e-06	0.000188	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—PIK3CG—pancreatic cancer	9.45e-06	0.000185	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—ARG2—pancreatic cancer	9.22e-06	0.00018	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—PPARG—pancreatic cancer	9.13e-06	0.000179	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	9.09e-06	0.000178	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—PTEN—pancreatic cancer	9.06e-06	0.000177	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—PIK3CB—pancreatic cancer	8.92e-06	0.000175	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—PIK3CB—pancreatic cancer	8.92e-06	0.000175	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—pancreatic cancer	8.9e-06	0.000174	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—APOE—pancreatic cancer	8.89e-06	0.000174	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—PTGS2—pancreatic cancer	8.83e-06	0.000173	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—PTGS2—pancreatic cancer	8.83e-06	0.000173	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—PIK3CG—pancreatic cancer	8.66e-06	0.00017	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—PPARG—pancreatic cancer	8.36e-06	0.000164	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—PIK3CD—pancreatic cancer	8.31e-06	0.000163	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—TYMP—pancreatic cancer	8.06e-06	0.000158	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—PIK3CG—pancreatic cancer	8.02e-06	0.000157	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—PPARG—pancreatic cancer	7.74e-06	0.000152	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—PTEN—pancreatic cancer	7.7e-06	0.000151	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—PTEN—pancreatic cancer	7.7e-06	0.000151	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—CD44—pancreatic cancer	7.62e-06	0.000149	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—PIK3CD—pancreatic cancer	7.62e-06	0.000149	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—GCG—pancreatic cancer	7.31e-06	0.000143	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—PIK3CB—pancreatic cancer	7.24e-06	0.000142	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—PTGS2—pancreatic cancer	7.18e-06	0.000141	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—PIK3CD—pancreatic cancer	7.05e-06	0.000138	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—STK11—pancreatic cancer	6.87e-06	0.000134	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—PIK3CB—pancreatic cancer	6.64e-06	0.00013	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—PTGS2—pancreatic cancer	6.58e-06	0.000129	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—GLP1R—pancreatic cancer	6.49e-06	0.000127	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—PIK3CA—pancreatic cancer	6.39e-06	0.000125	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—DPYD—pancreatic cancer	6.39e-06	0.000125	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—PTEN—pancreatic cancer	6.26e-06	0.000123	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—PIK3CB—pancreatic cancer	6.15e-06	0.00012	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—PTGS2—pancreatic cancer	6.09e-06	0.000119	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—SLC2A2—pancreatic cancer	6.06e-06	0.000119	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—TYMS—pancreatic cancer	5.91e-06	0.000116	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—PTEN—pancreatic cancer	5.74e-06	0.000112	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—PIK3CA—pancreatic cancer	5.44e-06	0.000106	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—PIK3CA—pancreatic cancer	5.44e-06	0.000106	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—PTEN—pancreatic cancer	5.31e-06	0.000104	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—AKT1—pancreatic cancer	5.22e-06	0.000102	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—APOE—pancreatic cancer	4.81e-06	9.41e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—CD44—pancreatic cancer	4.7e-06	9.19e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—GCG—pancreatic cancer	4.5e-06	8.81e-05	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—AKT1—pancreatic cancer	4.44e-06	8.69e-05	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—AKT1—pancreatic cancer	4.44e-06	8.69e-05	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—PIK3CA—pancreatic cancer	4.42e-06	8.65e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—PIK3CG—pancreatic cancer	4.34e-06	8.49e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—STK11—pancreatic cancer	4.23e-06	8.29e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—PPARG—pancreatic cancer	4.19e-06	8.2e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—PIK3CA—pancreatic cancer	4.05e-06	7.92e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—PIK3CD—pancreatic cancer	3.81e-06	7.46e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—PIK3CA—pancreatic cancer	3.75e-06	7.34e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—TYMS—pancreatic cancer	3.64e-06	7.13e-05	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—AKT1—pancreatic cancer	3.61e-06	7.06e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—PIK3CB—pancreatic cancer	3.32e-06	6.51e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—AKT1—pancreatic cancer	3.31e-06	6.47e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—PTGS2—pancreatic cancer	3.29e-06	6.45e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—AKT1—pancreatic cancer	3.06e-06	5.99e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—APOE—pancreatic cancer	2.96e-06	5.8e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—PTEN—pancreatic cancer	2.87e-06	5.62e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—PIK3CG—pancreatic cancer	2.67e-06	5.23e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—PPARG—pancreatic cancer	2.58e-06	5.05e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—PIK3CD—pancreatic cancer	2.35e-06	4.6e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—PIK3CB—pancreatic cancer	2.05e-06	4.01e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—PTGS2—pancreatic cancer	2.03e-06	3.97e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—PIK3CA—pancreatic cancer	2.03e-06	3.97e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—PTEN—pancreatic cancer	1.77e-06	3.46e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—AKT1—pancreatic cancer	1.66e-06	3.24e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—PIK3CA—pancreatic cancer	1.25e-06	2.44e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—AKT1—pancreatic cancer	1.02e-06	2e-05	CbGpPWpGaD
